drugset / Trial / NCT02115724

Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)

NCT02115724

RandomizedCrossoverDouble-blindTreatment

Summary

Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.

Timeline

Start
2014-04
Primary completion
2026-12
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.4 mg Other